We provide novel evidence that PTEN/PI3K/AKT signalling pathway could be regulated by YTHDC1 in an m6A‐dependent manner and highlight a critical role of YTHDC1 in cisplatin resistance of bladder cancer. Here, YTHDC1 is linked to urinary bladder cancer.